Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells

Medicine and Dentistry

• Advanced Glycation End Product Receptor 66%
• Cells 61%
• Programmed Cell Death 33%
• Advanced Glycation End-Product 33%
• Serum 16%
• Glucose 16%
• Insulin Release 16%
• Therapeutic Procedure 11%
• Protein 5%
• Antibody 5%
• Pathogenesis 5%
• Neuropathy 5%
• Gene Expression 5%
• Nephropathy 5%
• Complication of Diabetes 5%
• Mitochondrion Swelling 5%
• Complications of Diabetes Mellitus 5%
• Retinopathy 5%
• Caspase 5%
• Cytochrome C 5%
• Pancreatic Cell Line 5%

Biochemistry, Genetics and Molecular Biology

• Glycation 100%
• Apoptosis 33%
• Glucose 16%
• Insulin Release 16%
• Bcl-2 11%
• Rat 11%
• Insulin 5%
• Cytochrome 5%
• Gene Expression 5%
• Electric Potential 5%
• Caspase 5%
• Mitochondrion Swelling 5%
• Protein 5%
• Time 5%
• Dose 5%
• Antibody 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Advanced Glycation End Product Receptor 66%
• Advanced Glycation End Product 33%
• Glucose 16%
• Rat 11%
• Antibody 5%
• Protein 5%
• Cytochrome C 5%
• Insulin 5%
• Pathogenesis 5%
• Kidney Disease 5%
• Retinopathy 5%
• Neuropathy 5%
• Caspase 5%
• Diabetic Complication 5%